Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
solanezumab
Biotech
Roche refreshingly cautious on Alzheimer's hopeful gantenerumab
Roche’s pharma CEO is not getting dragged into hype over its effort gantenerumab.
Ben Adams
Feb 5, 2021 7:55am
Lilly and Roche's antibodies fail late-phase Alzheimer's test
Feb 10, 2020 6:51am
Analysts on amyloid thesis: It's not dead yet
Dec 9, 2016 4:51am
Lilly gives up on Alzheimer's hope solanezumab
Nov 23, 2016 8:08am
Alzheimer’s biotech Alzheon to move once-failed drug into new PhIII
Jul 25, 2016 9:30am